Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder

Geahča maid

• Characterizing mortality in patients with AQP4‐Ab + neuromyelitis optica spectrum disorder
  Dahkki: Francis, A, et al.
  Almmustuhtton: (2024)
• Characterizing mortality in patients with AQP4‐Ab+ neuromyelitis optica spectrum disorder
  Dahkki: Anna Francis, et al.
  Almmustuhtton: (2024-07-01)
• The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis
  Dahkki: Messina, S, et al.
  Almmustuhtton: (2021)
• Features of the diagnosis and treatment of patients with AQP-4-positive neuromyelitis optica and MOG antibody disease
  Dahkki: V. E. Avdeeva, et al.
  Almmustuhtton: (2021-11-01)
• Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders
  Dahkki: Elena H. Martinez-Lapiscina, et al.
  Almmustuhtton: (2016-09-01)